These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1384970)

  • 21. A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections.
    Li H; Lei X; Huang B; Rizak JD; Yang L; Yang S; Wu J; Lü L; Wang J; Yan T; Li H; Wang Z; Hu Y; Le W; Deng X; Li J; Xu L; Zhang B; Hu X
    J Neurosci Methods; 2015 Aug; 251():99-107. PubMed ID: 26003862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The catecholamine uptake blocker nomifensine protects against MPTP-induced parkinsonism in monkeys.
    Schultz W; Scarnati E; Sundström E; Tsutsumi T; Jonsson G
    Exp Brain Res; 1986; 63(1):216-20. PubMed ID: 3488228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.
    Morissette M; Goulet M; Soghomonian JJ; Blanchet PJ; Calon F; Bédard PJ; Di Paolo T
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):55-62. PubMed ID: 9387863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism.
    Graham WC; Robertson RG; Sambrook MA; Crossman AR
    Life Sci; 1990; 47(18):PL91-7. PubMed ID: 2250573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
    Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH
    Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    Neurosci Lett; 1985 Oct; 61(1-2):195-200. PubMed ID: 3878482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
    German DC; Dubach M; Askari S; Speciale SG; Bowden DM
    Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys.
    Goulet M; Madras BK
    J Pharmacol Exp Ther; 2000 Feb; 292(2):714-24. PubMed ID: 10640310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemiparkinsonism in monkeys following unilateral common carotid artery infusion of MPTP. A study of behavior, biochemistry and histology.
    Chen SD; Zhou XD; Xu DL; Li GW; Tang QM; Xu XR
    Chin Med J (Engl); 1991 Sep; 104(9):758-63. PubMed ID: 1935358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    Yoshimura N; Mizuta E; Yoshida O; Kuno S
    J Pharmacol Exp Ther; 1998 Jul; 286(1):228-33. PubMed ID: 9655864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.
    Zuddas A; Oberto G; Vaglini F; Fascetti F; Fornai F; Corsini GU
    J Neurochem; 1992 Aug; 59(2):733-9. PubMed ID: 1629743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
    Doudet DJ; Chan GL; Holden JE; McGeer EG; Aigner TA; Wyatt RJ; Ruth TJ
    Synapse; 1998 Jul; 29(3):225-32. PubMed ID: 9635892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits.
    Nakahara H; Nakazawa M; Tsukada T; Imai S
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):253-63. PubMed ID: 2415080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Yoshimura N; Mizuta E; Kuno S; Sasa M; Yoshida O
    Neuropharmacology; 1993 Apr; 32(4):315-21. PubMed ID: 8098860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.
    Schultz W; Studer A; Jonsson G; Sundström E; Mefford I
    Neurosci Lett; 1985 Aug; 59(2):225-32. PubMed ID: 3877257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subthalamotomy improves MPTP-induced parkinsonism in monkeys.
    Guridi J; Herrero MT; Luquin R; Guillen J; Obeso JA
    Stereotact Funct Neurosurg; 1994; 62(1-4):98-102. PubMed ID: 7631095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Clarke CE; Boyce S; Robertson RG; Sambrook MA; Crossman AR
    J Neurol Sci; 1989 May; 90(3):307-14. PubMed ID: 2786926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intrathecal infusion of brain-derived neurotrophic factor protects nigral dopaminergic neurons from degenerative changes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced monkey parkinsonian model].
    Takeda M
    Hokkaido Igaku Zasshi; 1995 Nov; 70(6):829-38. PubMed ID: 8582706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of plasma levels of large neutral amino acids and degree of parkinsonism on the blood-to-brain transport of levodopa in naive and MPTP parkinsonian monkeys.
    Alexander GM; Schwartzman RJ; Grothusen JR; Gordon SW
    Neurology; 1994 Aug; 44(8):1491-9. PubMed ID: 8058155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of D1 receptor stimulation in normal and MPTP monkeys.
    Bédard PJ; Boucher R
    Neurosci Lett; 1989 Sep; 104(1-2):223-8. PubMed ID: 2573015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.